Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01288651 | Iron Deficiency In Pulmonary Hypertension | ||
| NCT03047954 | Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT05136664 | Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects | ||
| NCT05034250 | Iron Status in Female Infertility and Recurrent Miscarriage | ||
| NCT01131624 | Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women | ||
| NCT00706667 | Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery | ||
| NCT00810030 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | ||
| NCT05897684 | Avacostar - (PASS) | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT00821717 | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure | ||
| NCT03888066 | Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) | ||
| NCT05751772 | Improving Knowledge in Heart Failure Inpatient With Therapeutic Education | ||
| NCT05625542 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients | ||
| NCT01438359 | A Drug-Drug Interaction Study of Furosemide and PA21 | ||
| NCT05786469 | Patiromer Trial in CKD Stage IIIB to V | ||
| NCT00868439 | Evaluation of Patiromer in Heart Failure Patients | ||
| NCT03759964 | Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery | ||
| NCT04510792 | IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors | ||
| NCT05514951 | Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment | ||
| NCT03781089 | Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients | ||
| NCT01477411 | A Drug-Drug Interaction Study of Digoxin and PA21 | ||
| NCT03214627 | Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial | ||
| NCT00746551 | Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment | ||
| NCT01110356 | Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT01453608 | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency | ||
| NCT03644264 | PA21 Safety and Efficacy in Adult Chinese Subjects | ||
| NCT02937454 | Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency | ||
| NCT00520780 | Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) | ||
| NCT02147795 | The German Patient Blood Management Network | ||
| NCT02694744 | Patiromer With or Without Food for the Treatment of Hyperkalemia | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT01820949 | Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients | ||
| NCT02213653 | Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency | ||
| NCT05766839 | Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels | ||
| NCT00824460 | Study of Phosphate Levels in Patients With Chronic Kidney Disease | ||
| NCT02557477 | Omega 3/6 Fatty Acids for Reading in Children | ||
| NCT03574311 | Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery | ||
| NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT03957187 | Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation | ||
| NCT05885763 | Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis | ||
| NCT04364269 | Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia | ||
| NCT01394562 | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure | ||
| NCT02688764 | A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia | ||
| NCT01057004 | EVIdence Based TreAtment - Heart Failure (EVITA-HF) | ||
| NCT00994318 | Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT04249648 | Hyperkalaemia and Its Impact on Therapy with RAASi |
